家庭雾化吸入糖皮质激素治疗在儿科呼吸系统疾病中的应用
详细信息 查看官网全文
- 论文作者：史翠红 ; 韩玮 ; 安小军 ; 李晓光 ; 刘艳清 ; 王振霞
- 年：2016
- 作者机构：蔚县人民医院;张家口市建国医院;张家口市肺科医院;康保县人民医院;怀安县妇幼保健院;
- 论文关键词：家庭雾化吸入 ; 糖皮质激素 ; 儿科呼吸系统疾病
- 英文论文关键词：family atomizing inhalation ; Glucocorticoids ; Pediatric respiratory system disease。
- 会议召开时间：2016-11-25
- 会议录名称：湖南中医药大学学报2016/专集：国际数字医学会数字中医药分会成立大会暨首届数字中医药学术交流会论文集
- 语种：中文
- 分类号：R725.6
- 学会代码：HNZY
- 会议名称：国际数字医学会数字中医药分会成立大会暨首届数字中医药学术交流会
- 会议地点：中国广东珠海
- 主办单位：国际数字医学会、Digital Chinese Medicine
- 学会名称：湖南中医药大学期刊杂志社
- 页数：1
- 文件大小：1808k
- 原文格式：D
- 会议级别：全国
摘要
目的:对家庭雾化吸入糖皮质激素在儿科呼吸系统疾病中的应用分析。方法:选取我院从2014年3月到2016年4月收治的132例儿科呼吸系统疾病患儿作为研究对象,采用随机分组的方式将其分为对照组和观察组,每组各66例。对照组患者给予常规的治疗,而观察组在此基础上给予家庭雾化吸入糖皮质激素治疗,对两组患者临床疗效以及不良反应进行对比。结果:观察组与对照组患者总有效率分别为,在临床有效率方面观察组明显高于对照组,具有可比性,P<0.05。观察组与对照组术后不良反应发生率分别为,观察组明显低于对照组,两组对比差异明显,具有统计学意义,P<0.05。结论:小儿呼吸系统疾病治疗中运用家庭雾化吸入糖皮质激素治疗,给药及时,能够提升治疗效果,同时还能降低不良反应发生率,值得大力推广。
objective: to family atomizing inhaled corticosteroids in the analysis of application of pediatric respiratory diseases. Selection methods: our hospital from March 2014 toApril 2016 treated 132 cases of pediatric respiratory system disease of children as the research object, by using random grouping, it can be divided into control group and observation group, 66 casesin each group. Control group given conventional treatment, patients with the observation group based on the given family atomization inhalation of glucocorticoid treatment, the two groups of patientswith clinical curative effect and adverse reaction were compared. Results: observation group and control group total effectiveness respectively, in patients with significantly due to the control groupin clinical efficient group, comparable, P < 0.05). Observation group and control group in incidence of postoperative adverse reactions, respectively, observe group, significantly lower than controlgroup obviously difference compared the two groups, statistically significant, P < 0.05). Conclusion: pediatric respiratory disease treatment using household atomizing inhaled corticosteroids inthe treatment, delivery timely, can improve the treatment effect, at the same time also can reduce the incidence of adverse reactions, is worth promoting.
objective: to family atomizing inhaled corticosteroids in the analysis of application of pediatric respiratory diseases. Selection methods: our hospital from March 2014 toApril 2016 treated 132 cases of pediatric respiratory system disease of children as the research object, by using random grouping, it can be divided into control group and observation group, 66 casesin each group. Control group given conventional treatment, patients with the observation group based on the given family atomization inhalation of glucocorticoid treatment, the two groups of patientswith clinical curative effect and adverse reaction were compared. Results: observation group and control group total effectiveness respectively, in patients with significantly due to the control groupin clinical efficient group, comparable, P < 0.05). Observation group and control group in incidence of postoperative adverse reactions, respectively, observe group, significantly lower than controlgroup obviously difference compared the two groups, statistically significant, P < 0.05). Conclusion: pediatric respiratory disease treatment using household atomizing inhaled corticosteroids inthe treatment, delivery timely, can improve the treatment effect, at the same time also can reduce the incidence of adverse reactions, is worth promoting.
引文
[1]殷勇,尚云霄.家庭雾化吸入糖皮质激素治疗在儿科呼吸系统疾病中的应用[J].临床儿科杂志.2014,15(2):144-145.
[2]夏春林.家庭雾化吸入糖皮质激素治疗在儿科呼吸系统疾病中的应用[J].延边医学.2015,32(12):123-126.
[3]HS Lim,MC Sun,J Lee,SP Yong,SM Lee.Responsiveness to inhaled corticosteroid treatment in patients with asthma–chronic obstructive pulmonary disease overlap syndrome[J].Annals of Allergy Asthma&Immunology Official.,2014,113(6):652-653.
[4]PD Scanlon.Pneumonia associated with inhaled corticosteroid use in chronic obstructive pulmonary disease:another perspective[J].Mayo Clinic Proceedings,2014,89(2):139-141.
[5]闫玉群.家庭雾化吸入糖皮质激素治疗在儿科呼吸系统疾病中的应用价值[J].中国继续医学教育.2016,24(2):1256-1258.
[6]杨荣峰,薛秀丽,白丽华.雾化吸入疗法在儿科呼吸系统疾病中的应用与研究[J].现代中西医结合杂志.2015,27(13):99-100.
[7]Y Yan,P Department,XC Hospital.Application Value of Family Atomization Inhalation of Glucocorticoid in the Treatment of Pediatric Respiratory Diseases[J].China Continuing Medical Education,2016,18(8):102-103.
[8]M Jakopovic,MJ Makeke,I Sabol,JV Ingen,L Zmak.Systemic corticosteroid and inhalation corticosteroid therapy are associated with nontuberculous mycobacterial pulmonary disease[J].European Respiratory Journal,2015,46-59.
[2]夏春林.家庭雾化吸入糖皮质激素治疗在儿科呼吸系统疾病中的应用[J].延边医学.2015,32(12):123-126.
[3]HS Lim,MC Sun,J Lee,SP Yong,SM Lee.Responsiveness to inhaled corticosteroid treatment in patients with asthma–chronic obstructive pulmonary disease overlap syndrome[J].Annals of Allergy Asthma&Immunology Official.,2014,113(6):652-653.
[4]PD Scanlon.Pneumonia associated with inhaled corticosteroid use in chronic obstructive pulmonary disease:another perspective[J].Mayo Clinic Proceedings,2014,89(2):139-141.
[5]闫玉群.家庭雾化吸入糖皮质激素治疗在儿科呼吸系统疾病中的应用价值[J].中国继续医学教育.2016,24(2):1256-1258.
[6]杨荣峰,薛秀丽,白丽华.雾化吸入疗法在儿科呼吸系统疾病中的应用与研究[J].现代中西医结合杂志.2015,27(13):99-100.
[7]Y Yan,P Department,XC Hospital.Application Value of Family Atomization Inhalation of Glucocorticoid in the Treatment of Pediatric Respiratory Diseases[J].China Continuing Medical Education,2016,18(8):102-103.
[8]M Jakopovic,MJ Makeke,I Sabol,JV Ingen,L Zmak.Systemic corticosteroid and inhalation corticosteroid therapy are associated with nontuberculous mycobacterial pulmonary disease[J].European Respiratory Journal,2015,46-59.